Prime Bio Inc.

Dartmouth, MA

UEI
L3EDB8218ZM5
CAGE
1XHV7
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
Other NAICS codes in SAM.gov
SAM.gov registration date
Physical address
86 Faunce Corner Mall Rd #410a, Dartmouth, MA 02747, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
Botulinum type b native heavy chain W81XWH09P0078 Medical Command (Army) $37,530
BB115, heavy chain type b W81XWH07P0738 Medical Command (Army) $16,960
BB101 botulinal toxin a complex HHSF223200610767P Food and Drug Administration $12,775
000HCRP9-2006-36580 - bbtech, INC HHSD2002006M18649P CDC Office of Acquisition Services $4,900
Purchase Order W81XWH05P0498 Medical Command (Army) $6,220

Latest 5 listed here. See the rest on GovTribe.

Grant awards

SBA capabilities narrative

Prime Bio, Inc. is a leading product and service provider in the field of botulinum neurotoxins and other neurological products. Founded in 1998 in Massachusetts , USA , Prime Bio has steadily expanded its product lines and services related to the synthesis, detection and applications of botulinum neurotoxins in numerous areas.

Quick answers

Is Prime Bio Inc. registered in SAM.gov?

Yes. Prime Bio Inc.'s SAM.gov registration is active through March 19, 2027.

What is Prime Bio Inc.'s most recent federal award?

Prime Bio Inc.'s most recent federal grant award is Botulinum neurotoxin trafficking and tissue distribution with mouse body imaging (R03AI103868), from National Institutes of Health, on May 23, 2013.

On GovTribe

See Prime Bio Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors